-DOCSTART- -X- O
Tylophorine -X- _ B-Intervention
compounds -X- _ I-Intervention
have -X- _ O
been -X- _ O
the -X- _ O
focus -X- _ O
of -X- _ O
drug -X- _ O
development -X- _ O
for -X- _ O
decades. -X- _ O
Tylophorine -X- _ B-Intervention
derivatives -X- _ I-Intervention
exhibit -X- _ O
anti-cancer -X- _ O
activities -X- _ O
but -X- _ O
their -X- _ O
cellular -X- _ O
targets -X- _ O
remain -X- _ O
unknown. -X- _ O
We -X- _ O
used -X- _ O
a -X- _ O
biotinylated -X- _ B-Intervention
tylophorine -X- _ I-Intervention
derivative -X- _ I-Intervention
to -X- _ O
probe -X- _ O
for -X- _ O
the -X- _ O
interacting -X- _ O
cellular -X- _ O
target -X- _ O
( -X- _ O
s -X- _ O
) -X- _ O
of -X- _ O
tylophorine. -X- _ O
Tylophorine -X- _ B-Intervention
directly -X- _ O
binds -X- _ O
to -X- _ O
caprin-1 -X- _ O
and -X- _ O
consequently -X- _ O
enhances -X- _ B-Outcome
the -X- _ I-Outcome
recruitment -X- _ I-Outcome
of -X- _ I-Outcome
G3BP1 -X- _ I-Outcome
, -X- _ I-Outcome
c- -X- _ I-Outcome
Myc -X- _ I-Outcome
mRNA -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
cyclin -X- _ I-Outcome
D2 -X- _ I-Outcome
mRNA -X- _ I-Outcome
to -X- _ I-Outcome
form -X- _ I-Outcome
a -X- _ I-Outcome
ribonucleoprotein -X- _ I-Outcome
complex. -X- _ I-Outcome
Subsequently -X- _ O
, -X- _ O
this -X- _ O
tylophorine -X- _ O
targeted -X- _ O
ribonucleoprotein -X- _ O
complex -X- _ O
is -X- _ O
sequestered -X- _ O
to -X- _ O
the -X- _ O
polysomal -X- _ O
fractions -X- _ O
and -X- _ O
the -X- _ O
protein -X- _ O
expressions -X- _ O
of -X- _ O
the -X- _ O
associated -X- _ O
mRNA-transcripts -X- _ O
are -X- _ O
repressed. -X- _ O
Caprin-1 -X- _ B-Outcome
depleted -X- _ I-Outcome
carcinoma -X- _ I-Outcome
cells -X- _ I-Outcome
become -X- _ I-Outcome
more -X- _ I-Outcome
resistant -X- _ I-Outcome
to -X- _ I-Outcome
tylophorine -X- _ I-Outcome
, -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
decreased -X- _ I-Outcome
formation -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
ribonucleoprotein -X- _ I-Outcome
complex -X- _ I-Outcome
targeted -X- _ I-Outcome
by -X- _ I-Outcome
tylophorine. -X- _ I-Outcome
Consequently -X- _ O
, -X- _ O
tylophorine -X- _ B-Outcome
downregulates -X- _ I-Outcome
c- -X- _ I-Outcome
Myc -X- _ I-Outcome
and -X- _ I-Outcome
cyclins -X- _ I-Outcome
D1 -X- _ I-Outcome
/ -X- _ I-Outcome
D2 -X- _ I-Outcome
, -X- _ I-Outcome
causing -X- _ I-Outcome
hypophosphorylation -X- _ I-Outcome
of -X- _ I-Outcome
Rb -X- _ I-Outcome
and -X- _ I-Outcome
suppression -X- _ I-Outcome
of -X- _ I-Outcome
both -X- _ I-Outcome
processing- -X- _ I-Outcome
body -X- _ I-Outcome
formation -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
Warburg -X- _ I-Outcome
effect. -X- _ I-Outcome
Gene -X- _ O
expression -X- _ O
profiling -X- _ O
and -X- _ O
gain-of-c-Myc-function -X- _ O
experiments -X- _ O
also -X- _ O
revealed -X- _ O
that -X- _ O
the -X- _ O
downregulated -X- _ O
c-Myc -X- _ O
contributes -X- _ O
to -X- _ O
the -X- _ O
anti-oncogenic -X- _ O
effects -X- _ O
of -X- _ O
tylophorine -X- _ O
compounds. -X- _ O
Furthermore -X- _ O
, -X- _ O
the -X- _ B-Outcome
potent -X- _ I-Outcome
tylophorine -X- _ I-Outcome
derivative -X- _ I-Outcome
dibenzoquinoline-33b -X- _ I-Outcome
elicited -X- _ I-Outcome
a -X- _ I-Outcome
similar -X- _ I-Outcome
effect -X- _ I-Outcome
, -X- _ I-Outcome
as -X- _ I-Outcome
c-Myc -X- _ I-Outcome
protein -X- _ I-Outcome
levels -X- _ I-Outcome
were -X- _ I-Outcome
also -X- _ I-Outcome
decreased -X- _ I-Outcome
in -X- _ I-Outcome
xenograft -X- _ I-Outcome
tumors -X- _ I-Outcome
treated -X- _ I-Outcome
with -X- _ I-Outcome
dibenzoquinoline-33b. -X- _ I-Outcome
Thus -X- _ O
, -X- _ O
tylophorine -X- _ B-Outcome
compounds -X- _ I-Outcome
exert -X- _ I-Outcome
anti- -X- _ I-Outcome
cancer -X- _ I-Outcome
activity -X- _ I-Outcome
predominantly -X- _ I-Outcome
by -X- _ I-Outcome
targeting -X- _ I-Outcome
and -X- _ I-Outcome
sequestering -X- _ I-Outcome
the -X- _ I-Outcome
caprin-1 -X- _ I-Outcome
protein -X- _ I-Outcome
and -X- _ I-Outcome
c-Myc -X- _ I-Outcome
mRNA -X- _ I-Outcome
associated -X- _ I-Outcome
ribonucleoprotein -X- _ I-Outcome
complex -X- _ I-Outcome
. -X- _ O

